Scientific paper - Original scientific paper
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

Marso, Stiven P.; McGuire, Darren K.; Zinman, Bernard; Poulter, Neil R.; Emerson, Scott S.; Pieber, Thomas R.; Pratley, Richard E.; Haahr, Poul-Martin; Lange, Martin; Brown-Frandsen, Kirstine; Moses, Alan; Skibsted, Simone; Kvist, Kajsa; Buse, John B. (2017)

Cite this document

Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R. ... Buse, J. B. (2017). Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. New England Journal of Medicine, 377. (8), 723-732. doi: 10.1056/NEJMoa1615692

Marso, Stiven P., et al. "Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes." New England Journal of Medicine, vol. 377, no. 8, 2017, pp. 723-732. https://doi.org/10.1056/NEJMoa1615692

Marso, Stiven P., Darren K. McGuire, Bernard Zinman, Neil R. Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, et al. "Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes." New England Journal of Medicine 377, no. 8 (2017): 723-732. https://doi.org/10.1056/NEJMoa1615692

Marso, S. P., et al. (2017) 'Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes', New England Journal of Medicine, 377(8), pp. 723-732. doi: 10.1056/NEJMoa1615692

Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, and sur.. Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. New England Journal of Medicine [Internet]. 2017 [cited 2020 August 05];377(8):723-732. doi: 10.1056/NEJMoa1615692

S. P. Marso, et al., "Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes", New England Journal of Medicine, vol. 377, no. 8, pp. 723-732, 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:239:882161. [Accessed: 05 August 2020]

Islandora Bookmark - Please login to use this feature